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Abstract
Background: The survival time of patients with head and neck squamous cell carcinoma (HNSCC) is related to
health behavior, such as tobacco smoking and alcohol consumption. Poor oral health (OH), dental care (DC) and
the frequent use of mouthwash have been shown to represent independent risk factors for head and neck
cancerogenesis, but their impact on the survival of HNSCC patients has not been systematically investigated.
Methods: Two hundred seventy-six incident HNSCC cases recruited for the ARCAGE study were followed through a
period of 6–10 years. Interview-based information on wearing of dentures, gum bleeding, teeth brushing, use of floss
and dentist visits were grouped into weighted composite scores, i.e. oral health (OH) and dental care (DH). Use of
mouthwash was assessed as frequency per day. Also obtained were other types of health behavior, such as smoking,
alcohol drinking and diet, appreciated as both confounding and study variables. Endpoints were progression-free
survival, overall survival and tumor-specific survival. Prognostic values were estimated using Kaplan-Meier analysis and
Cox proportional hazards regression models.
Results: A good dental care score, summarizing annual dental visits, daily teeth cleaning and use of floss was
associated with longer overall survival time (p = .001). The results of the Cox regression models similarly suggested a
higher risk of tumor progression and shortened overall survival in patients with poor dental care, but the results
lost their statistical significance after other types of health behavior had been controlled for. Frequent use of
mouthwash (≥ 2 times/day) significantly increased the risk of tumor-specific death (HR = 2.26; CI = 1.19–4.32).
Alcohol consumption and tobacco smoking were dose-dependently associated with tumor progression and
shorter overall survival.
Conclusion: Frequent mouthwash use of ≥ 2 times/day seems to elevate the risk of tumor-specific death in
HNSCC patients. Good dental care scores are associated with longer overall survival.
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Background
Head and neck squamous cell carcinomas (HNSCC)
account for 90 % of all head and neck cancers. Loca-
tions include the lip, oral cavity, pharynx and larynx.
HNSCC is the 6th most common cancer worldwide [1].
It accounts for approximately 100,000 cases diagnosed
annually in the European Union, and the incidence is
increasing [2–4].
Tobacco smoking, alcohol consumption, HPV infec-
tion and socioeconomic factors are established risk fac-
tors for cancer development in the head and neck
region [5–8]. Dietary factors, such as the consumption
of vegetables and fruits, have been described as having
a protective effect [9–13]. A growing body of evidence
suggests that a lack of dental care and poor oral health
have to be considered as independent risk factors for
HNSCC development [14–17].
Many of the established risk factors for cancerogenesis
in the head and neck region also have a prognostic
value, as has been demonstrated in follow-up studies of
patients with incident HNSCC [5, 18–20]. Studies largely
agree about the effect of smoking and HPV status on
survival. Alcohol consumption and diet as independent
variables for overall or progression-free survival are con-
troversial [18, 20–22].
In contrast, the potential effect of dental care, oral
health and mouthwash use on survival in head and neck
cancer patients have not been systematically investi-
gated. Therefore, this study was designed to determine
whether oral health, dental care and mouthwash use
have prognostic value for the survival of HNSCC pa-
tients. Two novel, recently published scores for assessing
dental care and oral health status [14] were used in
addition to the evaluation of other types of health behav-
ior, such as smoking, drinking, and vegetable consump-
tion. All lifestyle variables were tested for their effect on
overall survival, tumor progression and tumor-specific
survival of HNSCC patients.
Methods
Study population
Two hundred seventy-six incident cases (Germany) with
pathologically confirmed diagnosis of head and neck
squamous cell carcinoma (HNSCC) were originally re-
cruited in a multicenter study (ARCAGE) [7]. Locations
comprised the oral cavity (C01-C06), tonsils (C09),
pharynx (C10-C13) and larynx (C32). Cases with in-situ
carcinoma, esophagus cancer, cancer of the vermillion
border, the paranasal sinuses and salivary glands were
not included.
Information about risk factor exposure, including
oral hygiene behavior, was assessed through standard-
ized computer assisted personal interviews during the
ARCAGE study. All subjects signed a form ensuring
informed consent, ethical approval was given by the
IARC ethical review board. For the follow-up study,
pathological data were collected from cancer registries
supplemented by pathology reports. The tumor stage
was assessed according to UICC (Tumor, Node, Metas-
tasis [TNM] stage I-IV). Cancer treatment such as
radiotherapy, chemotherapy and surgery was abstracted
from clinical records. The average follow-up time cov-
ered a period of 8 years (range 6–10). Survival data,
such as cause of death or occurrence of metastasis or
relapse (tumor progression), were obtained from local
health departments, medical practitioners and the Bre-
men mortality index [23].
Health behavior variables
Interview-based assessment of oral hygiene habits and
other health behavior variables was performed during
hospitalization of HNSCC patients. The median time
point of the Interview was 6 days after primary tumor
treatment, interview questions referred to the time
period of one year or more prior to diagnosis. Oral
health and dental care were represented by weighted
composite scores, which were constructed a priori
based on repeatedly reported variables associated with
HNSCC [14, 15, 24]. As shown in Additional file 1:
Table S1, the oral health (OH) score involved a 0–7
scale and the dental care (DC) score a 0–8 scale, with
higher numbers indicating poorer oral health or dental
care. In brief, each variable summarized the information
on three indicators. The oral health score accounted for
wearing dentures, age at which patient started to wear
dentures and the frequency of gum bleeding. Gum bleed-
ing usually occurs during chronic periodontitis and can
contribute to cancerogenesis [25–27]. Individuals not suf-
ficiently taking care of their teeth and gum tend to wear
dentures earlier in life. Missing teeth alone have been
shown increase HNSCC risk [15]. Poor fitting dentures
are associated with a 4-fold increased risk for oral cancer
[24]. The dental care score comprised number of dentist
visits per year, frequency of teeth cleaning and use of floss.
Use of mouthwash was measured as frequency per day,
regardless of its formulation. Composite scores and
mouthwash were grouped into two categories. Here, an
OH score of 6–7, a DC score of 3–8 and mouthwash
use ≥ 2/d served as the exposure, ensuring that the cat-
egories included a meaningful number of subjects. The
other categories were defined as reference. In a sensi-
tivity analysis, hazard ratios for oral hygiene habits
were estimated using different types of categorization
in order to minimize the probability for misleading re-
sults (Additional file 2: Table S2).
Smoking behavior was operationalized by pack-years
(20 cigarettes per day multiplied by number of years),
smoking frequency (cigarettes per day) and smoking
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duration (years). “Smokers” were defined as individuals
smoking cigarettes, cigars, pipe, or any tobacco product
at least once per week for a year [7]. Participants who
had stopped smoking less than 1 year ago or by the time
of tumor diagnosis were classified as current smokers.
Alcohol consumption was operationalized by drink-
years (drinks per day multiplied by number of years),
drinking frequency (number of drinks per day) and
drinking duration (years of alcohol consumption). The
definition of one alcoholic drink equivalent was 18 ml
of pure alcohol, which generally corresponds to 330 ml
of beer, 150 ml of wine and 36 ml of hard liquor [7].
Participants who had stopped drinking alcohol less than
1 year ago or by the time of tumor diagnosis were classi-
fied as current drinkers. Cumulative exposure variables as
pack-years and drink-years reflect the product of intensity
and duration of the exposure and are good predictors for
many exposure-response relationships [28]. Diet was oper-
ationalized by fruit and vegetable consumption (consump-
tion frequency per week, type of fruit). The patients’
education was represented by years of school education
(< 10 years [≤ ISCED level 2], ≥ 10 years).
HPV assessment
Human papilloma virus (HPV) DNA was detected using
PCR methods as established before [29]. 150 ng tumor
DNA was extracted from formalin-fixed, paraffin embed-
ded tissues from primary tumor sites (Quiagen, Hilden,
Germany) and eluted in 25 μl molecular grade water. In-
cubation with 0.5 U Uracil-DNA-Glycosylase (UNG) for
5 min at 20° was followed by thermal inactivation of UNG
for 2 min at 95 °C. The PCR was performed with an initial
denaturation (30 s at 98 °C), followed by denaturation (6 s
at 98 °C), annealing (15 s at 40 °C) and elongation (5 s at
72 °C) including a final elongation step for 3 min at 72 °C.
To verify that HPV high risk types 16 and 18 were de-
tected, the following primers were used: HPV16- AT
ATAAGGGGTCGGTGGACCG, GCAATGTAGGTGTA
TCTCCATGC and HPV18- AAGGATGCTGCACCGGC
TGAA, CACGCACACGCTTGGCAGGTTT). The PCR
(PCR core plus, Roche, Switzerland) was performed fol-
lowing to the manufacturer’s protocol, using incubation
with 0.5 U Uracil-DNA-Glycosylase (UNG) for 5 min at
20 °C and consecutive thermal inactivation of UNG for
2 min at 95 °C. The PCR (35 amplification cycles) was per-
formed with an initial denaturation (30 s at 98 °C),
followed by denaturation (20 s at 98 °C), annealing (15 s at
55 °C) and elongation (20 s at 72 °C) including a final
elongation step for 3 min at 72 °C.
Outcomes
The study outcomes were overall survival, tumor pro-
gression free survival and tumor-specific survival. Over-
all survival was defined as time between tumor diagnosis
and death or end of the study. Tumor progression was
defined as time between diagnosis and occurrence of
metastasis or tumor relapse. Tumor-specific survival was
defined as time between HNSCC diagnosis to death re-
lated to the primary tumor or to the end of the study.
Progression-free survival was used if patients stayed alive
without tumor relapse during the observational period.
If no further visits to health departments/medical practi-
tioners were documented (loss to follow up), the last day
of a documented visit to a health department/medical
practitioner was the time point of censoring. In the set-
ting of tumor-specific survival, those patients were cen-
sored who had not died from their HNSCC. Ethical
approval was given by the institutional review board of
the Medical Association Bremen (44-110-10.10/4).
Statistical methods
Curves of overall survival were obtained by the Kaplan-
Meier method. Differences in survival between groups
were determined by the log-rank test. A Cox propor-
tional hazards regression model was applied to assess
the association between lifestyle variables and the end-
points overall survival, tumor progression and tumor-
specific survival, considering a significance level of α =
5 %. The Cox regression model was adjusted for sex,
age, tumor stage according to UICC criteria (stage I-IV
and missing), tumor site (oral cavity (C01-C06), tonsils
(C09), pharynx (C10-C13) and larynx (C32), treatment
(radiotherapy, surgery and chemotherapy measured as
yes and no/unknown responses), education (more or less
than ten years of education), smoking (pack-years), alco-
hol consumption (drink-years), vegetable and fruit con-
sumption (times per week) and HPV-16/18-infection
status of the tumor, which are established influencing
factors for HNSCC patient survival [8, 20, 30] . Smoking
and alcohol consumption were examined as continuous
variables after natural logarithmic transformation. Miss-
ing values were categorized as separate category and in-
cluded in the analyses to make use of the entire sample.
Statistical analyses were performed using the statistical
software package SAS 9.3.
Results
Patient characteristics
Table 1 displays the patient characteristics of 276 inci-
dent cases of head and neck squamous cell carcinoma
(HNSCC). The male–female ratio was 5:1, the mean
age was 58 years (SD ± 9). Almost 70 % of the patients
had received less than 10 years of school education.
The majority of patients had tumors of the oral cavity
(n = 89, 32 %), the larynx (n = 76, 28 %) and of the phar-
ynx (n = 72, 26 %). Less frequent were tumors of the
tonsils (n = 39, 14 %). Most patients with available infor-
mation on tumor stage had stage IV tumors (n = 125,
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45 %). Tumor stages I/II/III were nearly uniformly distrib-
uted (n = 22/33/27). If one of the mandatory grading
parameters T (primary tumor), N (regional lymph nodes)
and M (distant metastasis) was not reported, tumor
classification (UICC) could not been derived and was
set to missing. The majority of 228 patients (83 %)
underwent surgery; 184 patients (67 %) had radiother-
apy as single or adjuvant treatment and in 107 patients
(39 %) chemotherapy was administered. Overall, 24 of
191 patients (12.6 %) with available HPV test results
had HPV-related squamous cell carcinoma. HPV status
was set to missing if tumor tissue was not collected
during the ARCAGE study. In agreement with previous
studies, the incidence of HPV association was low
among patients with HNSCC of the oral cavity (8.2 %).
Conversely, in 40.7 % of patients with tonsillar HNSCC
an exposure to high risk HPV could be detected.
HNSCC of the larynx in our collective had the lowest
HPV incidence (3.8 %), which might be due to the small
number of samples and the high number of missing
values of the HPV status.
Dental care and oral health
Table 2 illustrates the distributions of the composite var-
iables dental care and oral health among potentially con-
founding health behaviors. 159 patients (58 %) reported
good dental care as defined (DC ≤ 2, Table 2). Poor den-
tal care (score of 3–6) was seen in 38 patients (14 %).
None of the patients had a poorer dental care than score
6. Thirty patients (11 %) stated that they used mouth-
wash more than once a day. Indicators of poor oral
health (wearing of dentures, gum bleeding) were present
in 62 patients (22 %). In contrast, 194 patients claimed
good oral health (70 %). Values for DC were missing in
79 cases and for OH in 20 cases.
Looking at the distribution of the other types of health
behavior, such as smoking and alcohol consumption, it
is noteworthy that the mean number of pack-years
within the patient cohort was 41 (median: 37 pack-
years). The mean number of drink-years was 79 (median:
41 drink-years). The mean frequency of vegetable and
fruit servings was 5 per week.
Missing data in health behavior variables resulted
from a missing response for the respective item in the
questionnaire.
Influence of dental care, oral health and mouthwash on
different survival endpoints
A good dental care score, represented by annual dental
visits, daily teeth cleaning and use of floss, showed a sig-
nificant benefit looking at the overall survival time in a
Kaplan-Meier analysis (Fig. 1). The difference in median
survival time between patients with good vs poor dental
care was 81 months (p < 0.001). Hazard ratios of the Cox
regression model (Table 3) imply that lack of dental care
might contribute to the risk of earlier death or tumor
progression in HNSCC patients (1.5-fold), but the effect
was not statistically significant. Looking at the endpoint
of tumor-specific survival, frequent mouthwash use, i.e.
more than once a day, showed a significant effect (HR =
2.26; CI 95 % = 1.19–4.32), indicating that patients with
frequent mouthwash use are more likely to die because
Table 1 Demography and clinico-pathological data of patients
with head and neck squamous cell carcinoma (HNSCC)
Men Women All
(N = 230) (N = 46) (N = 276)
Demography
Age (years)
Mean (SD) 58.2 (8.5) 57.0 (11.4) 58.0 (9.0)
Median (IQR) 58.0 (12.0) 58.0 (15.0) 58.0 (12.0)
Range 41–77 32–77 32–77
Education (years)
< 10 164 (73.3 %) 25 (54.4 %) 189 (68.5 %)
≥ 10 66 (28.7 %) 21 (45.6 %) 87 (31.5 %)
Clinico-pathological characteristics
Stage (UICCa)
I 19 (8.3 %) 3 (6.5 %) 22 (8.0 %)
II 28 (12.2 %) 5 (10.9 %) 33 (12.0 %)
III 19 (8.3 %) 8 (17.4 %) 27 (9.8 %)
IV 106 (46.1 %) 19 (41.3 %) 125 (45.3 %)
Missing 58 (25.2 %) 11 (23.9 %) 69 (25.0 %)
Tumor site
C01-C06 (Oral cavity) 70 (30.4 %) 19 (41.3 %) 89 (32.3 %)
C09 (Tonsils) 34 (14.8 %) 5 (10.9 %) 39 (14.1 %)
C10-C13 (Pharynx) 56 (24.4 %) 16 (34.8 %) 72 (26.1 %)
C32 (Larynx) 70 (30.4 %) 6 (13.0 %) 76 (27.5 %)
Radiotherapy
No/unknown 78 (33.9 %) 14 (30.4 %) 92 (33.3 %)
Yes 152 (66.1 %) 32 (69.6 %) 184 (66.7 %)
Surgery
No/unknown 38 (16.5 %) 10 (21.7 %) 48 (17.4 %)
Yes 192 (83.5 %) 36 (78.3 %) 228 (82.6 %)
Chemotherapy
No/unknown 145 (63.0 %) 24 (52.2 %) 169 (61.2 %)
Yes 85 (37.0 %) 22 (47.8 %) 107 (38.8 %)
HPV status (16, 18)
Negative 142 (61.7 %) 25 (54.4 %) 167 (60.5 %)
Positive 19 (8.3 %) 5 (10.9 %) 24 (8.7 %)
Missing 69 (30.0 %) 16 (34.8 %) 85 (30.8 %)
aUnion of International Cancer Classification
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of their tumor disease. Overall survival and tumor pro-
gression were also negatively influenced by frequent
mouthwash use, but no statistically significant effect
could be demonstrated (Table 3). Frequency of gum
bleeding and wearing dentures (oral health score) did
not show an effect on HNSCC prognosis.
A strong, dose-dependent association between sur-
vival time and lifestyle variables was seen for smoking
and drinking habits. Under the assumption of propor-
tional hazards, the risk of tumor recurrence or death
(overall survival, HR = 2.83; CI 95 % = 1.22–6.58) was
increased nearly threefold for patients who smoked 20
cigarettes per day. A drinking frequency of 5 drinks/day
showed a stronger adverse effect on survival (overall
survival, HR = 1.87; CI 95 % = 1.22–2.87) than an accu-
mulation of 10 drink-years (overall survival, HR =1.59;
CI 95 % = 1.14–2.24).
Apart from mouthwash use, tumor-specific survival
was significantly reduced by a drinking frequency of 2
drinks/day (HR = 1.52; CI 95 % = 1.08–2.12). The num-
ber of vegetable or fruit servings per week had no influ-
ence on patient survival (data not shown).
Discussion
Our study demonstrates that annual dental visits, daily
teeth cleaning and use of floss (low dental care score)
are associated with longer overall survival in patients
with head and neck squamous cell carcinoma (HNSCC).
Frequent mouthwash use (≥ 2 times/day) was associated
with a twofold increased risk of tumor-specific death in
HNSCC patients after other lifestyle factors had been
controlled for. Hazard ratios for the association between
poor dental care and the risk of death or tumor progres-
sion were consistently elevated over all endpoints, but
not statistically significant. Smoking and alcohol con-
sumption were dose-dependently associated with a max-
imally threefold higher risk of tumor progression and
shortened overall survival.
Table 2 Health behavior of patients with head and neck
squamous cell carcinoma (HNSCC)
Men Women All
(N = 230) (N = 46) (N = 276)
Dental Carea
0–2 (good) 130 (56.5 %) 29 (63.0 %) 159 (57.6 %)
3–6 (bad) 36 (15.7 %) 2 (4.4 %) 38 (13.8 %)
Missing 64 (27.8 %) 15 (32.6 %) 79 (28.6 %)
Oral Healtha
0–5 (good) 165 (71.7 %) 29 (63.0 %) 194 (70.3 %)
6–7 (bad) 47 (20.4 %) 15 (32.6 %) 62 (22.5 %)
Missing 18 (7.8 %) 2 (4.4 %) 20 (7.3 %)
Mouthwash (times per day)
< 2 202 (87.8 %) 42 (91.3 %) 244 (88.4 %)
≥ 2 26 (11.3 %) 4 (8.7 %) 30 (10.9 %)
Missing 2 (0.9 %) 0 (0.0 %) 2 (0.7 %)
Pack-years
Mean (SD) 44.1 (26.2) 27.7 (20.4) 41.4 (26.0)
Median (IQR) 40.0 (26.1) 25.7 (19.2) 36.8 (27.6)
Range 0–203 0–92 0–203
Missing 3 0 3
Smoking frequency (per day)
Mean (SD) 23.6 (12.1) 16.3 (10.5) 22.4 22.4 (12.1)
Median (IQR) 20.1 (11.0) 15.9 (12.1) 20.0 (11.2)
Range 0–104 0–44 0–104
Missing 3 0 3
Smoking duration (years)
Mean (SD) 36.2 (11.8) 31.0 (14.3) 35.3 (12.4)
Median (IQR) 37.5 (13.0) 34.0 (11.0) 37.0 (12.5)
Range 0–60 0–49 0–60
Missing 2 0 2
Drink-years
Mean (SD) 87.5 (101.7) 35.1 (92.5) 78.7 (101.9)
Median (IQR) 46.5 (101.8) 13.4 (26.7) 41.0 (83.5)
Range 0–573 0–621 0–621
Missing 3 0 3
Drinking frequency (per day)
Mean (SD) 2.6 (3.1) 1.1 (2.9) 2.3 (3.1)
Median (IQR) 1.4 (2.8) 0.4 (0.8) 1.1 (2.7)
Range 0–16 0–19 0–19
Missing 3 0 3
Drinking duration (years)
Mean (SD) 36.5 (11.0) 28.3 (15.3) 35.1 (12.2)
Median (IQR) 36.5 (15.0) 31.0 (20.0) 36.0 (15.0)
Range 0–61 0–53 0–61
Missing 2 0 2
Table 2 Health behavior of patients with head and neck
squamous cell carcinoma (HNSCC) (Continued)
Vegetable consumption
Mean (SD) 4.4 (2.6) 5.1 (3.2) 4.5 (2.7)
Median (IQR) 4.0 (5.0) 4.0 (4.0) 4.0 (4.7)
Range 0–14 1–14 0–14
Missing 9 3 12
aThe dental care score comprised number of dentist visits per year, frequency
of teeth cleaning and use of floss. The oral health score accounted for wearing
dentures, age at which patient started to wear dentures and frequency of
gum bleeding. Composite scores and mouthwash were grouped into two
categories. Here, an OH score of 6–7, a DC score of 3–6 and mouthwash use
≥ 2/d served as the exposure, ensuring that the categories included a
meaningful number of subjects
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Fig. 1 Kaplan-Meier curves showing the differences in overall survival time between patients with good dental care/oral health (=blue) and poor
dental care/oral health (= red). The difference in median survival time is 81 months for dental care (a) and 23 months for oral health (b)
Table 3 Hazard ratios (HR) for the influence of health behavior variables on tumor survival in HNSCC patients




(n = 263) 95 % CI (n = 254) 95 % CI (n = 261) 95 % CI
Dental care scoreb
Score 0–2 1.00 Ref. 1.00 Ref. 1.00 Ref.
Score 3–6 (poor care) 1.30 0.78–2.15 1.48 0.89–2.45 1.51 0.79–2.88
Mouthwash used
Mouthwash < 2 times/day 1.00 Ref. 1.00 Ref. 1.00 Ref.
Mouthwash≥ 2 times/day 1.32 0.76–2.31 1.47 0.88–2.47 2.26 1.19–4.32
Oral health scorec
Oral health 0–5 1.00 Ref. 1.00 Ref. 1.00 Ref.
Oral health 6–7
(poor health)
1.05 0.69–1.60 1.11 0.74–1.67 0.85 0.47–1.54
Smoking log[pack-years + 1]
10 pack-years 2.05 1.17–3.61 1.89 1.11–3.24 1.72 0.83–3.56
20 pack-years 2.46 1.21–4.97 2.22 1.14–4.34 1.97 0.79–4.89
Smoking freq log[cigarettes + 1]
10 cigarettes/day 2.30 1.17–4.52 2.04 1.07–3.89 2.06 0.83–5.09
20 cigarettes/day 2.83 1.22–6.58 2.44 1.09–5.46 2.47 0.80–7.64
Drinking (drink-years)
log[drinkyears + 1]
10 drink-years 1.59 1.14–2.24 1.53 1.10–2.11 1.90 1.21–2.99
20 drink-years 1.79 1.17–2.74 1.70 1.13–2.55 2.23 1.27–3.93
Drinking freq log[drinks + 1]
2 drinks/day 1.47 1.13–1.90 1.52 1.18–1.97 1.52 1.08–2.12
5 drinks/day 1.87 1.22–2.87 1.99 1.31–3.04 1.97 1.14–3.41
Bold numbers indicate statistically significant log rank tests and HR
Abbreviations: freq frequency, log logarithmic transformation, Ref reference
aHazard ratios: Cox regression model adjusted for age, sex, tumor site, tumor stage, treatment, education, smoking, alcohol drinking, HPV status. Hazard ratios
describe the risk of death, tumor progression or tumor specific death within the observational period; bincludes information on brushing teeth, use of floss,
dentist visits cincludes information on wearing dentures, age at wearing dentures, gum bleeding; dindependent variable
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Poor oral hygiene habits are independent risk factors
for the development of HNSCC in multiple studies
[14–16, 31, 32], but the operationalization of habits and
adjustment for confounder is not homogenous at all.
The ARCAGE study (2002–2005) [14], to date the lar-
gest multicenter case–control study included 1963 can-
cer patients’ vs 1993 control subjects. Novel composite
scores for dental care and oral health were developed
as the summary of previously reported criteria like
wearing of dentures, frequency of gum bleeding, teeth
brushing, use of brush/toothpaste/floss and regular
dentist visits [15, 16, 24]. Although not validated by in-
spections of the mouth and a possible recall bias of the
interview- based assessment, Ahrens et al. observed
consistent associations between the scores and upper-
aerodigestive tract cancers across different subsites.
Using these composite weighted scores, we first evalu-
ated the prognostic relevance of oral hygiene habits on
survival in 276 HNSCC patients. Patients with good
oral hygiene habits lived significantly longer, but the
results of the Cox regression analysis controlling for
established survival predictors like age, sex, tumor
stage, tumor site, treatment, education, HPV status,
smoking and alcohol consumption, were insignificant.
Nevertheless, elevated hazard ratios suggest that good
dental care might positively influence survival in
HNSCC patients, but the informative value is limited
by the small sample size of our study. Gum bleeding
and wearing of dentures (parameters of the oral health
score) did not have an effect on tumor survival in uni-
variate or multivariate analysis.
That frequent mouthwash use significantly increased
the risk of tumor-specific death, support the hypothesis
that mouthwash contributes to the development and
evolution of HNSCC. Several studies speculate about an
association of mouthwash and head and neck cancer de-
velopment [32–34]. Earlier works found that especially
alcohol containing mouthwashes elevate the risk of oral
and pharyngeal cancer [33]. A more recent study by
Eliot et al. [16] showed that both alcoholic and non-
alcoholic mouthwashes are a risk for HNSCC when
used at least once per day. In contrast, a quantitative
meta-analysis by Gandini et al. [35] revealed no signifi-
cant associations between mouthwash and oral cancer
risk. Within the ARCAGE cohort, there was a 3.5-fold
risk increase of head and neck cancer development
(sites included mouth, oropharynx, hypopharynx, lar-
ynx and esophagus) in individuals using alcoholic or
non-alcoholic mouthwashes three or more times daily
compared to never-users [14]. Like in our follow up
study using ARCAGE data, unfortunately no discrimin-
ation could be made between alcoholic and non-
alcoholic mouthwashes. Similarly, the overall lifetime
exposure to mouthwash was not assessed. Nevertheless,
the impact of mouthwash use on HNSCC risk could be
demonstrated, whilst confounding such as tobacco use, al-
cohol consumption and HPV status has been controlled
for through logistic regression models. Also it has been
suggested that mouthwash use might simply be a “mask-
ing” behavior to get rid of the smokers’ breath [36]. In a
study investigating oral hygiene habits of smokers and
non-smokers, the frequency of mouthwash use did not
differ between the two groups [37].
In agreement with other studies we observed that smok-
ing and alcohol consumption were dose-dependently asso-
ciated with a higher risk of shortened overall survival of
HNSCC patients. A study by Mayne and colleagues [21]
on 264 patients showed a significant influence of alcohol
and tobacco consumption on survival in early stage cancer
in the oral cavity, the pharynx and the larynx. In the pro-
spective part of the study, Mayne et al. stated that the risk
of dying was increased twofold in patients who continued
to drink alcohol. Continued smoking did not increase the
risk of dying. A study by Duffy and colleagues [20] investi-
gating the influence of various (pretreatment) health
behaviors, found that smoking was the strongest inde-
pendent predictor of survival among 504 head and neck
cancer patients, but not alcohol consumption. In our ana-
lysis of the influence of alcohol consumption, we calcu-
lated that the risk of tumor progression associated with
drinking frequencies of 2 drinks per day was increased
1.5-fold. While we modeled alcohol consumption and
smoking as log-transformed continuous variables, many
studies use categorized variables, which may increase the
probability of false positive results [38].
Second cancers following oral and pharyngeal cancers
as endpoint with respect to the smoking and drinking be-
havior were investigated by Day et al. [18]. This follow-up
study on 1090 patients recruited in a population-based
case–control study showed that the risk of a second aero-
digestive tract cancer increased fourfold among smokers
who had smoked more than 40 years compared to
smokers who had smoked less than 20 years at the time of
diagnosis. Among alcohol consuming individuals, the risk
of local tumor recurrence was increased threefold in the
head and neck region [18]. In our study we observed a
2.2-fold increased risk of tumor progression (observed
events included tumor recurrences) associated with 20
pack-years and a 1.7-fold increased risk associated with 20
drink-years.
In contrast to some of the mentioned follow-up stud-
ies, we did not obtain follow-up information on health
behavior through second interviews because many pa-
tients had died at the time of follow up assessment. It is
worthy of note that significant survival prediction, as
documented in many studies [20, 21, 39], mostly refer to
pretreatment health behavior. The stronger effect of pre-
treatment compared to posttreatment lifestyle behavior
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is also supported by Franceschi and colleagues [22].
Their study, including 754 head and neck cancer
patients, showed that ceasing drinking at the time of
cancer diagnosis does not have a clearly favorable effect
on survival. Marron et al. demonstrated that quitting
alcohol drinking reduces the risk for HNSCC develop-
ment not before 20 years of abstinence, while smoking
cessation reduced the risk after 1–4 years [40]. The
favorable effect of smoking cessation on recurrence rates
and tumor survival has been demonstrated by many
studies summarized in a comprehensive review by van
Imhof et al. [41].
Conclusion
In conclusion, frequent mouthwash might be an inde-
pendent prognostic factor for tumor-specific survival.
Good dental care, comprising annual dental visits,
daily teeth cleaning and use of floss is associated with
longer overall survival, but the trend could not be
proven by Cox regression analysis. Alcohol consump-
tion and tobacco smoking were dose-dependently as-
sociated with tumor progression and shorter overall
survival.
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